Orlistat vs Wegovy vs Mounjaro: Three Distinct Weight Loss Medication Mechanisms
For anyone searching for orlistat vs Wegovy, the key difference is simple: Orlistat works by reducing the amount of fat absorbed from food, while Wegovy (semaglutide) is a GLP 1 receptor agonist that acts on appetite regulation. In clinical studies, Wegovy was associated with greater average weight loss than Orlistat, although individual results may vary. Mounjaro (tirzepatide) offers another option by activating both GLP 1 and GIP receptors, providing a different treatment approach for eligible adults to discuss with their prescriber.
This comparison is designed for adults in the UK who want to learn about prescription weight management treatments that may be available through a regulated online service. Below, we compare how Orlistat, Wegovy, and Mounjaro work, their costs, clinical evidence, possible side effects, dosing schedules, storage guidance, travel considerations, and how ordering through EverydayMeds works. Understanding these differences can help you discuss the most appropriate treatment option with your healthcare professional.
When comparing Orlistat vs Wegovy, one of the main differences is how the medicines work. Orlistat is a pancreatic lipase inhibitor that reduces the absorption of around 30% of dietary fat in the intestines. Wegovy (semaglutide) is a GLP 1 receptor agonist that helps regulate appetite. Mounjaro (tirzepatide) works differently by activating both GLP 1 and GIP receptors, offering another approach to weight management.
The comparison becomes broader when Mounjaro is included because it has a dual receptor mechanism. Orlistat is generally used alongside a reduced fat diet to help reduce gastrointestinal side effects, while Wegovy and Mounjaro work through hormone pathways involved in appetite regulation and feelings of fullness. Wegovy contains semaglutide, which targets GLP 1 receptors, while Mounjaro contains tirzepatide, which targets both GLP 1 and glucose dependent insulinotropic polypeptide (GIP) receptors. Both medicines are available only with a prescription and require an individual clinical assessment before treatment can be prescribed.
Pricing Comparison: Orlistat vs Wegovy vs Mounjaro Costs
Understanding the cost of Orlistat vs Wegovy involves looking at both the price of treatment and the type of treatment being prescribed. Orlistat typically costs around £20 to £40 per month through different providers, while Wegovy at EverydayMeds starts from £79.99 for the 0.25 mg starter dose (using code FIRST40 for new customers). The 2.4 mg maintenance dose of Wegovy costs £209.99, and bundle options such as the Intro Duo (0.25 mg and 0.5 mg) are available for £169.99. Mounjaro follows a similar pricing structure, reflecting the medicine and the prescribing process. If you are comparing a weight management tablet with an injection, generic Orlistat may be a lower cost option.
When comparing the cost of Orlistat vs Wegovy, it is also worth considering how each treatment is taken. Orlistat is taken daily, while Wegovy and Mounjaro are administered once weekly. EverydayMeds also offers bundle options, including the Getting Started and Stay Steady bundles, allowing eligible patients to order more than one prescribed dose where clinically appropriate. The Ultimate Stability Trio includes three months of the 2.4 mg maintenance dose for £649.99, and returning customers can use code DOSE25 at checkout. Wegovy and Mounjaro are prescription only medicines, while a lower strength of Orlistat is available without a prescription.
Clinical Evidence: Orlistat vs Wegovy vs Mounjaro Effectiveness
Clinical studies have shown different results for Orlistat, Wegovy, and Mounjaro when used for weight management. The STEP clinical trials found that participants using Wegovy alongside a reduced calorie diet and increased physical activity lost an average of around 15% of their starting body weight after 68 weeks, compared with 2.4% in the placebo group (Wilding et al., New England Journal of Medicine, 2021). Studies of Orlistat have reported average weight loss of around 5% of starting body weight over 1 to 2 years, although individual results vary. Clinical studies of Mounjaro, including the SURMOUNT 1 trial, also reported substantial weight loss, with participants receiving the highest dose achieving an average weight reduction of around 20.9% at the study endpoint.
When comparing Orlistat vs Wegovy, it is also important to consider differences in how the medicines work and their possible side effects. Orlistat's gastrointestinal side effects are related to reduced fat absorption, while Wegovy and Mounjaro share similar GLP 1 related side effects, such as nausea and reduced appetite. All three treatments require an individual clinical assessment before prescribing, and ongoing clinical review may be recommended where appropriate.
How Wegovy Works Compared to Orlistat and Mounjaro
Wegovy (semaglutide) supports weight management through its action as a GLP 1 receptor agonist. Unlike Orlistat, which works by reducing fat absorption in the digestive system, Wegovy mimics the natural GLP 1 hormone involved in appetite regulation. It helps regulate appetite, slows gastric emptying, and plays a role in blood glucose regulation. These effects may help some people feel fuller for longer, reduce food cravings, and support a reduced calorie diet.
Orlistat works differently by reducing the amount of fat absorbed from food and does not directly affect appetite. Although both medicines are used as part of a weight management plan, they work through different mechanisms.
Wegovy is administered once weekly using the FlexTouch pen, while Orlistat is taken with meals that contain fat. In the STEP 1 clinical trial, around 83.5% of participants taking Wegovy lost at least 5% of their starting body weight after 68 weeks, compared with around 60% of participants taking Orlistat who achieved at least 5% weight loss after 6 months in clinical studies.
Compared with Mounjaro, which activates both GLP 1 and GIP receptors, Wegovy works by selectively targeting GLP 1 receptors. Both medicines have been evaluated in clinical studies for weight management, although the studies were conducted separately and should not be
Ordering Process: Accessing Wegovy and Mounjaro vs Orlistat
The prescribing process is different when comparing Orlistat vs Wegovy through EverydayMeds. Our short online clinical consultation asks about your medical history, current medications, and weight management goals to help a qualified prescriber assess whether Wegovy or Mounjaro may be appropriate for you. Applications are usually reviewed within three working days. An express review may also be available, subject to clinical capacity.
Eligibility depends on your individual clinical circumstances. Wegovy may be considered for adults with a BMI of 30 or above, or 27 or above with a weight related health condition, such as high blood pressure or high cholesterol. Orlistat may be prescribed for adults with a BMI of 30 or above, or from a BMI of 28 or above if there is a qualifying weight related health condition. Your healthcare professional will also review your current medications and any relevant personal or family medical history before making a prescribing decision.
If treatment is prescribed, your medication can be supplied from our GPhC registered pharmacy (#9012878) using temperature controlled delivery to help maintain the manufacturer's recommended storage conditions during transport.
Unlike Wegovy and Mounjaro, which require a prescription following an individual clinical assessment, lower strength Orlistat is also available over the counter for some adults who meet the eligibility criteria. Prescription only treatments require a more detailed clinical review to help ensure they are appropriate for the individual.
Storage, Side Effects, and Practical Considerations: Orlistat vs Wegovy vs Mounjaro
Storage requirements are one of the practical differences when comparing Orlistat vs Wegovy. Orlistat capsules are stored at room temperature and taken daily. Wegovy should be stored in a refrigerator at 2°C to 8°C before first use and may be stored below 30°C for up to six weeks after first use, in line with the manufacturer's instructions. Mounjaro also requires refrigeration before first use and may be stored at room temperature for up to 21 days, according to the manufacturer's instructions.
Wegovy is administered once weekly using the FlexTouch pen. Treatment begins with a 0.25 mg starting dose and is increased gradually to the 2.4 mg maintenance dose over 16 weeks, following the licensed dosing schedule. During dose increases, some people may experience side effects such as abdominal discomfort, which may improve as the body adjusts. This gradual dose escalation is intended to help improve tolerability compared with starting treatment at a higher dose.
Injectable vs Oral: Delivery Method Comparison
The way these treatments are taken is one of the main differences when comparing Orlistat vs Wegovy. Orlistat is an oral capsule taken with meals that contain fat. Wegovy and Mounjaro are administered as subcutaneous injections using prefilled pens. Although some people may feel uncertain about injections at first, many find the once weekly dosing schedule convenient after receiving appropriate guidance.
When comparing Orlistat vs Wegovy, the once weekly injection schedule may be more convenient for some people than taking a tablet with each fat containing meal. Wegovy and Mounjaro can be injected into the thigh, abdomen, or upper arm, and it is recommended to rotate injection sites to help reduce the risk of injection site reactions. During dose increases, some people may experience side effects such as abdominal discomfort.
Orlistat works differently and is most effective when taken with meals containing fat as part of a reduced calorie, lower fat diet. Because it reduces the absorption of dietary fat, some people may experience gastrointestinal side effects, such as oily stools, increased bowel movements, or flatulence. Following the dietary advice provided by your healthcare professional may help reduce these side effects.
Making Your Choice: Orlistat vs Wegovy vs Mounjaro Decision Factors
Choosing between Orlistat vs Wegovy depends on your individual medical history, lifestyle, and weight management goals. A qualified healthcare professional can help you decide which treatment may be appropriate for your needs.
Some people may prefer Orlistat because it is an oral medicine and may have a lower upfront cost. Others may prefer the convenience of the once weekly injection schedule offered by Wegovy or Mounjaro. Orlistat works best when used alongside a reduced fat, reduced calorie diet and may require a multivitamin supplement. It can also cause gastrointestinal side effects, such as oily stools and flatulence.
Both Wegovy and Mounjaro are available through EverydayMeds, subject to an individual clinical assessment and, where appropriate, a prescription from a qualified prescriber. Our clinical team provides ongoing support throughout treatment alongside advice on dietary changes and increased physical activity.
Only one prescription weight management medicine is generally recommended at a time. If you have questions about rapid weight loss, low blood sugar, blood glucose management, or combining treatments, speak to your healthcare professional before starting or changing treatment. If you are considering prescription weight management treatment, you can begin an online clinical assessment to find out whether it may be appropriate for you.
